Goldman Sachs Future Health Care Equity ETF(GDOC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 13 days
PROFIT SINCE LAST BUY
+3.09% ▲
LAST CLOSE
$39.33
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GDOC

11/13/2026: GDOC (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Goldman Sachs Future Health Care Equity ETF (GDOC) provides active exposure to global healthcare companies driving structural innovations such as genomics, precision medicine, and digital health. Its main strengths lie in professional active management by Goldman Sachs and targeted exposure to high-conviction disruptive trends. The fund serves as a satellite growth allocation for investors seeking specialized medical sector participation. Key risks include a high expense ratio, concentrated holdings, and sensitivity to regulatory and interest rate pressures. It suits growth-focused investors who want active thematic exposure while monitoring ongoing fund liquidity and performance relative to broad healthcare benchmarks.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe fund targets innovative healthcare companies with high long-term earnings growth potential.
Momentum investorStrong fit while signal remains positiveMomentum suitability depends on an ongoing positive technical upturn across disruptive healthcare equities.
Value investorWeak fitThe portfolio emphasizes growth and disruptive innovation over traditional value metrics.
Dividend/Income investorWeak fitGDOC focuses on capital appreciation and offers a negligible dividend yield.
Low-risk investorWeak fitConcentrated active management and exposure to emerging biotech introduce substantial volatility.

Investor Profile

Ideal Investor Profile

Growth-oriented investors seeking active, thematic exposure to the future of global healthcare and willing to accept higher expense ratios and volatility.

Suitability

Best suited for long-term investors looking to complement a core portfolio with high-conviction healthcare innovation exposure.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighActive focus on disruptive medical tech and smaller caps leads to sharp price swings.
Market riskMedium / highEquities are susceptible to broad healthcare sector downturns and macroeconomic shifts.
ConcentrationHighThe fund holds a limited number of positions, concentrating risk in top holdings.
Tracking/expenseMedium / highAn expense ratio of 0.75% requires strong alpha generation to overcome costs.
LiquidityMedium / highLower assets under management can result in wider spreads and lower daily trading volume.
Business/sector qualityMediumRelies heavily on the clinical success and regulatory approval paths of underlying innovators.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

GDOC exhibits elevated historical volatility due to its active exposure to disruptive medical technologies and growth-oriented equities.

Market Risk

The fund is vulnerable to sector-specific regulatory shocks, clinical trial setbacks, and macroeconomic cycles affecting growth assets.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorGlobal Healthcare Equities (Focus on Genomics, Precision Medicine, and Biotech)100Provides targeted exposure to disruptive medical technologies and healthcare innovation leaders worldwide.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit 15.59%
Avg. Invested days 43
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.